Profile for Lithuania Patent: C1971601
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Lithuania Patent: C1971601
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 12,171,739 | Nov 15, 2026 | Boehringer Ingelheim | HERNEXEOS | zongertinib |
| 8,648,087 | Jan 14, 2031 | Seagen | TUKYSA | tucatinib |
| 9,693,989 | May 9, 2027 | Seagen | TUKYSA | tucatinib |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
